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Abstract
Background: We have previously reported that p53 mutated radioresistant lymphoma cell lines
undergo mitotic catastrophe after irradiation, resulting in metaphase arrest and the generation of
endopolyploid cells. A proportion of these endopolyploid cells then undergo a process of de-
polyploidisation, stages of which are partially reminiscent of meiotic prophase. Furthermore,
expression of meiosis-specific proteins of the cancer/testis antigens group of genes has previously
been reported in tumours. We therefore investigated whether expression of meiosis-specific genes
was associated with the polyploidy response in our tumour model.
Methods: Three lymphoma cell lines, Namalwa, WI-L2-NS and TK6, of varying p53 status were
exposed to a single 10 Gy dose of gamma radiation and their responses assessed over an extended
time course. DNA flow cytometry and mitotic counts were used to assess the kinetics and extent
of polyploidisation and mitotic progression. Expression of meiotic genes was analysed using RT-
PCR and western blotting. In addition, localisation of the meiotic cohesin REC8 and its relation to
centromeres was analysed by immunofluorescence.
Results: The principal meiotic regulator MOS was found to be significantly post-transcriptionally
up-regulated after irradiation in p53 mutated but not p53 wild-type lymphoma cells. The maximum
expression of MOS coincided with the maximal fraction of metaphase arrested cells and was
directly proportional to both the extent of the arrest and the number of endopolyploid cells that
subsequently emerged. The meiotic cohesin REC8 was also found to be up-regulated after
irradiation, linking sister chromatid centromeres in the metaphase-arrested and subsequent giant
cells. Finally, RT-PCR revealed expression of the meiosis-prophase genes, DMC1, STAG3, SYCP3 and
SYCP1.
Conclusion: We conclude that multiple meiotic genes are aberrantly activated during mitotic
catastrophe in p53 mutated lymphoma cells after irradiation. Furthermore, we suggest that the
coordinated expression of MOS and REC8 regulate the extent of arrested mitoses and polyploidy.
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Background
DNA damage induces a G2 phase cell-cycle arrest in most
tumour cell lines that lack functional p53 protein. Follow-
ing abrogation of the G2 checkpoint, these cells arrest in
mitosis and can subsequently form polyploid cells. This
response is thought to represent an alternative to immedi-
ate death through apoptosis. This abnormal arrest in
mitosis and the subsequent formation of mono-and
multi-nucleated endopolyploid giant cells is incorporated
under the collective term 'mitotic catastrophe' [1]. The
mechanisms underlying such responses remain unclear
[1-4]. Our group has previously described the morpholog-
ical features of these endopolyploid cells and observed
that certain stages of the cytological rearrangements that
lead to their de-polyploidisation, and return to mitosis are
partly reminiscent of meiotic prophase [5,6]. Interest-
ingly, ectopic expression of meiotic proteins of the so-
called cancer/testis antigens group, namely SCP1 and
SPO11, has been reported in the literature as a feature of
progressing tumours [7-9] and it has been suggested that
this phenomenon could represent a link between the
malignant behaviour of tumours and a gametogenesis-
like processes [10-12].
One of the central signalling pathways involved in switch-
ing cells from mitosis to meiosis is regulated by the MOS
kinase. During meiosis, MOS is translationally up-regu-
lated, where it first stimulates the first reduction division
of the cell and then further acts as a cytostatic factor to
maintain the oocyte in metaphase arrest at meiosis II until
fertilization occurs [13]. These separate functions are
attributed to two different downstream targets of the
MOS/MAPK pathway, cdk1 and Rsk90, respectively. In
addition, MOS directly interacts with kinetochores
thereby interrupting mitosis [14].
Meiosis functions to generate cells with a reduced number
of chromosome sets. There are two obligate and interde-
pendent requirements for this reduction division: (1) Sis-
ter chromatid cohesion and homologous chromosome
pairing to facilitate the correct segregation and reduction
of maternal and paternal chromosomes; (2) recombina-
tion between homologous chromosomes [15,16]. Pivotal
to these processes is the meiotic cohesin REC8 [17,18]
which sustains the cohesion between sister chromatids
and particularly centromeres preventing separation until
anaphase II [19]. Rec8 functions to ensure that both
homolog pairing and reduction division occurs during
meiosis. Recently, Rec8 dominant negative mutants have
been shown to prevent synapse formation of homologs in
mammalian cells [20], whilst in yeast mutants over-
expressing REC8 fail to produce sister chromatid separa-
tion [21].
During pre-meiotic replication REC8 associates with an
axial structure on the meiotic chromosomes which later
forms the lateral element of the synaptonemal complex
(SC) [22]. REC8 has been found to form complexes with
the meiosis-specific recombinase DMC1 [23]. This
enzyme is necessary for the Rad51-mediated stable DNA
strand invasion and homology search which occurs dur-
ing the homologous recombination stages of meiosis
[24]. Other important proteins of the SC are SCP3 and
SCP2 which form the lateral elements of the SC. A third
protein, SCP1 forms the central element of the SC, provid-
ing a bridge to hold the two homologous chromosomes
together, assisted by recombination chiasma between the
homologs [25-27]. REC8 colocalizes with another meiosis
specific cohesin, STAG3. STAG3 stabilizes cohesion
between sister chromatids during meiosis I and together
with REC8 marks the lateral element of the SC [28].
Thus, REC8 and MOS, together with a number of specific
cohesins and recombinases are important in the regula-
tion and execution of meiosis, combining to achieve
homologous recombination and chromosome separa-
tion/reduction. Although the molecular machinery for
meiotic reduction divisions is largely understood, little is
known regarding the regulation of reduction division in
somatic polyploid cells which is thought to be a rare event
[29]. We hypothesised that polyploid cells may have the
same common regulators involved in reduction division
as meiosis on the basis that meiosis has probably evolved
as a means of reducing the chromosome number in asex-
ual polyploid protists [10,30]. Therefore, we sought to
address whether the transformations observed in the
endopolyploid tumour cells were linked with the ectopic
expression of these genes. In this study we demonstrate
Table 1: Sequences of primers used in the RT-PCR experiments.
Gene Forward Reverse Primer
MOS 5'-CGGTGTTCCTGTGGCCATAA 5'-GCAGGCCGTTCACAACATC
REC8 5'-TGAGGGTGAATGTGGTGAAA 5'-CTGGGATTGCAGCCTCTAAG
SYCP3 5'- TGCAGAAAGCTGAGGAACAA 5'-TGCTGCTGAGTTTCCATCAT
SYCP1 5'- TGGCGATGTGATGGAATTTA 5'- TGTTTTCCCCATTTTTGGAG
SPO11 5'- AGGAAGATGGCACCAAAGTG 5'-GGTCCCTTTTTGTCAGTGGA
STAG3 5'- GGATGCAAAGCTACAGCA 5'- CATCCGGTCCTTGAAGC
DMC1 5'- AGCAGCAAAGTTCCATGAAG 5'- TGAGCTCTCCTCTTCCCTTTBMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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the expression of several key meiotic prophase genes
including MOS, SYCP1, REC8, DMC1, STAG3 and SYCP3
in tumour cells.
Methods
Cell lines and irradiation of cells
The Burkitt's lymphoma cell line Namalwa was obtained
from the American Type Culture Collection (ATCC) and
carries mutated p53 [31]. The TK6 and WI-L2-NS human
lymphoblastoid cell lines were derived from the same WI-
L2 isolate and were obtained from Dr. P. Olive (Vancou-
ver, Canada). TK6 cells are p53 wild type and WI-L2-NS
p53-mutated [32]. The p53 mutation status of all three
cell lines was confirmed by sequencing analysis. Cells
were grown in RPMI 1640 medium, 10 % Foetal Calf
Serum (FCS; Gibco, Paisley, UK) at 37°C in a 5 % CO2
humidified incubator. Cells were maintained in log phase
of growth for at least 24 hours prior to irradiation which
was at a density of 5 × 105 cells/ml using a Gulmay D3 225
X-ray source at a dose rate of 0.77 Gy/min. Cell culture
medium was replenished every 48–72 hours.
Mitotic counts and DNA flow cytometry
Mitotic counts were measured from cytospins stained for
DNA. Metaphases, anaphases and telophases were
counted per 1000 cells, in at least three independent
experiments. DNA flow cytometry for detection of poly-
ploid cells (>4C) was performed as described previously
[32].
Isolation of mRNA and conversion into cDNA
mRNA was isolated using the microquickprep mRNA kit
(Amersham Pharmacia Biotech UK Ltd, Little Chalfont,
UK) and converted to cDNA using the first strand cDNA
synthesis kit (Amersham Pharmacia Biotech UK Ltd)
according to the manufacturer's instructions.
RT-PCR
Reverse transcription polymerase chain reaction (RT-PCR)
was performed in thin walled PCR tubes with 100 ng of
cDNA, 100 ng of 5' and 3' primers, 1 unit (U) of DNA
polymerase in the presence of dNTPs, 1 × reaction buffer
and Taq polymerase (Promega, Southampton, UK). DNA
was denatured at 95°C for 1 min, followed by 30 amplifi-
cation cycles, using an annealing temperature of 56°C
and extension at 72°C. The sequences of primers used are
listed in Table 1. PCR products were analysed by electro-
phoresis in 1–2 % agarose gels and visualized under UV
light after staining with ethidium bromide.
Sequencing
To verify the sequence of the RT-PCR products, additional
PCR experiments were performed with Pfu polymerase
rather than Taq. These products were gel purified and
cloned into PCR-Blunt II- TOPO vector (Invitrogen Life
Technologies, UK). Sequencing was performed with T7
and sp6 primers along with standard PCR dye based di-
deoxy chain termination technology and analyzed on an
AB Prism 377 sequencer (Perkin-Elmer Applied Biosys-
tems, Warrington, UK). The MOS  nucleotide sequence
was submitted to GenBank (accession number
AY279177).
Western blotting
Western blotting was performed on cytoplasmic cell
lysates to detect MOS and β-actin proteins accordingly to
the methods as previously described [33]. The anti-
nuclear REC8 antibody (Santa Cruz Biotech.) was used to
detect REC8. For MOS detection, 2 × 106 cells were lysed
in 100 µl of 2× PSB, sonicated for 30 seconds, heated at
96°C for 5 minutes, resolved via 10% SDS-PAGE and
transferred to PVDF membranes. After incubation with
appropriately diluted primary antibodies (see Table 2),
membranes were incubated with horseradish peroxidase-
conjugated anti-mouse or anti-rabbit IgG (Sigma; Dorset,
UK) for 1 hour at room temperature and washed. Anti-
body binding was visualized by SuperSignal West Pico
Chemiluminescent Substrate (Pierce Biotechnology, Per-
bio Science UK Ltd., UK) before exposure to light-sensitive
film (Hyperfilm ECL, Amersham Pharmacia Biotech, UK).
Immunofluorescent (IF) staining
For immunofluorescent staining, harvested cells were sus-
pended in FCS, cytospun onto poly-L-lysine coated micro-
Table 2: Antibody source and usage
Primary antibodies Secondary antibodies
Polyclonal goat anti-human REC8 (E-18):sc-15152 (Santa Cruz) Rabbit anti-goat-Cy3 (Sigma)
Polyclonal rabbit anti-mouse REC8 antibody (602; kindly donated by Dr. 
C. Heyting, Wageningen, NL [23])
Goat anti-rabbit IgG-Texas red (Vector Laboratories Ltd., UK),
CREST serum against human kinetochore proteins (Acris Antibodies, 
Hiddenhausen, Germany)
Mouse anti-human IgG-FITC (Dr. MS Cragg)
Polyclonal rabbit anti-MOS (C237: sc-86; Santa Cruz Biotech;Wembley, 
UK)
Mouse anti-rabbit IgG-FITC (Sigma, Dorset, UK)
Polyclonal rabbit anti-SCP3 antiserum (kindly donated by Dr. C. Heyting, 
Wageningen, NL [46])
Goat anti-rabbit IgG-FITC (Vector Laboratories Ltd., UK),BMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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scope slides, fixed in absolute methanol for 10–20
minutes at -20°C. Slides were then rinsed in ice-cold ace-
tone, semi-dried and washed in PBS. Detection of various
proteins was performed with the respective antibodies
according to[34]. The pairs of antibodies used and their
source are presented in Table 2. Samples were counter-
stained with DAPI (0.5 µg/ml) (Molecular Probes, Cam-
bridge, UK). Slides were mounted in mowiol (Harlow
Post transcriptional accumulation of p39mos protein in response to 10 Gy irradiation Figure 1
Post transcriptional accumulation of p39mos protein in response to 10 Gy irradiation. (A) Transcription of MOS from 
Namalwa, WI-L2-NS or TK6 cells on different days after irradiation. Messenger RNA was first isolated from samples and then 
reverse transcribed to yield cDNA for semi-quantitative PCR. Primers for GAPDH were used to verify integrity and quantity 
of cDNA. Mos expression was observed in all 3 cell lines with minor differences seen during the five days after irradiation; (B) 
upper panel: in comparison to non-treated control (NT), accumulation of p39mos was detected by Western blotting on days 1 
to 4 afterirradiation, with maximum expression observed on days 2–3 in Namalwa, and days 1 and 2 for WI-L2-NS cells. In 
TK6 cells, p39mos was not detectable after irradiation. Lower panel: for loading control PVDF membranes were re-blotted 
with mouse monoclonal anti-b-actin antibodies.BMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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Chemical Company Ltd, UK), containing 0.1% citifluor
(Agar Scientific, Stansted, UK). Images were taken with a
Leica DM LS2 fluorescent microscope.
Results
Translation of MOS is enhanced by irradiation in p53 
mutated lymphoma cell lines
MOS  was transcriptionally expressed in all three lym-
phoma cell lines, and no significant changes were
detected following irradiation (Fig. 1A). However, when
protein expression was assessed by Western blotting, a
particularly pronounced accumulation of p39mos was
observed in Namalwa cells after irradiation (Fig. 1B) with
the peak levels of expression coinciding with the maximal
metaphase arrest on day 3 (Fig. 2A and 2B). The p39mos
expression was also elevated in WI-L2-NS cells after irradi-
ation, which again coincided with the maximum mitotic
arrest (in this case on day 2), albeit less pronounced (both
the expression of p39mos and cell arrest) than that
observed in the Namalwa cells. In contrast, p39mos pro-
tein was expressed at a very low level in p53 wild-type TK6
cells and its expression was not enhanced following irra-
diation. The expression level of p39mos also correlated
with the amount of polyploid cells produced (Fig. 2C).
These data suggest that the post-translational events
responsible for the induction of MOS only occur in p53
mutated irradiated lymphoma cells following irradiation.
Next we sought to examine the expression of the meiotic
cohesin REC8.
Expression of REC8 is enhanced after irradiation
Although transcribed at a low level in untreated cells,
REC8 was substantially up-regulated following irradiation
in all five independent experiments performed with the
Namalwa cell-line (Figure 3A). Up-regulation was
observed from day 3 until day 7–9 post-irradiation over
the period during which the largest number of polyploid
cells are present in the culture (Fig. 2C). REC8 was also
expressed in WI-L2-NS cells and elevated following irradi-
ation, albeit with different kinetics than that seen in
Namalwa cells where a prominent increase in transcrip-
tion was seen only from day 5. In contrast, in TK6 cells,
REC8 was transcribed prior to irradiation but its expres-
sion fell afterwards. Due to almost all of the TK6 cells
undergoing apoptosis by day 3, it was impossible to ana-
lyze expression levels on subsequent days. Western blot
analysis performed for REC8 protein in Namalwa cells
further confirmed the translation of this meiotic cohesion
protein over this protracted period post-irradiation with a
peak in protein expression on day 3 (Fig. 3B).
Distribution of REC8 in endopolyploid cells
Given the pronounced upregulation of REC8 following
irradiation, we next assessed the localisation of REC8 in
cells at various times after irradiation. As a positive control
for REC8 staining we first assessed two different antibod-
ies directed to REC8 on rat testes tissue and, as expected,
we observed strongly positive staining in the primary sper-
matocytes (Fig. 4A insert). Using the same antibodies, we
then assessed the expression of REC8 in the lymphoma
cells. Untreated Namalwa cells in interphase or undergo-
ing mitosis were negative for REC8. Interestingly, how-
ever, a few bright, large, REC8-positive foci were observed
Metaphase arrest and levels of polyploidy in lymphoma cell- lines after 10 Gy irradiation Figure 2
Metaphase arrest and levels of polyploidy in lymphoma cell-
lines after 10 Gy irradiation. p53 mutated Namalwa cells 
show a pronounced arrest in metaphase as seen by the high 
mitotic index on day 3 to day 5 (A) and near absence of ana-
phases and telophases (B) for a period of almost 10 days. 
Metaphase arrest is smaller and shorter in W1-L2-NS; (C) 
typical changes in the levels of polyploidy observed by DNA 
flow cytometry in Namalwa, W1-L2-NS and TK6 cells. (C) 
Reprinted from Ivanov et al., 2003. Both mitotic and endo-
cycling are abrogated in wt p53 TK6 cells, which do not sur-
vive this irradiation insult.BMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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in the chromatin of rare mitotic cells undergoing arrest in
metaphase (data not shown).
Following irradiation of Namalwa cells, bright REC8-pos-
itive foci appeared in about 10–15% of the cells on day 3.
These data are in accordance with the western blot REC8
protein expression coincident with the peak of mitotic
arrest. REC8 was localised within the arrested aberrant
metaphases characterised by the swollen and adhered
chromosomes (Fig 4A), evidently undergoing restitution
The expression of meiosis-specific genes DMC1, REC8, STAG3, SYCP1 and SYCP3 in irradiated lymphoma cells in the time- course post-irradiation: (A) Transcription of REC8, STAG3 and DMC1, shown by RT-PCR of mRNA isolated from WI-L2-NS,  TK6 or Namalwa cells on different days post irradiation and from non-treated control cells (NT) Figure 3
The expression of meiosis-specific genes DMC1, REC8, STAG3, SYCP1 and SYCP3 in irradiated lymphoma cells in the time-
course post-irradiation: (A) Transcription of REC8, STAG3 and DMC1, shown by RT-PCR of mRNA isolated from WI-L2-NS, 
TK6 or Namalwa cells on different days post irradiation and from non-treated control cells (NT). Primers for actin were used 
to verify integrity and quantity of cDNA; (B) Expression of REC8 protein in Namalwa cells, detected by Western blotting (anti-
body from Santa Cruz). The highest level of transcription was detected on day 3. Lower panel: for loading control PVDF mem-
branes were re-blotted with mouse monoclonal anti-b-actin antibodies. (C) Transcription of SYCP1 and SYCP3 shown by RT-
PCR of mRNA isolated from non treated Namalwa cells or on day 7 post irradiation showing very weak background expres-
sion. NB: In this experiment three times as much cDNA was used for the WI-L2-NS non treated samples as was used for the WI-L2-NS 
samples post irradiation. This was done in order to verify the increase in transcription after irradiation treatment. Although the amount of 
cDNA taken for PCR with the REC8 primers is much smaller on day 5 post irradiation (as judged by beta actin level) it still shows obvi-
ously higher level of REC8 expression.BMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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into interphase. After day 3, the amount of REC8 staining
increased in the nuclei of subsequent endopolyploid
interphase cells. During this period (day 3–6), DNA
endoreduplication and repair by homologous recombina-
tion were observed as documented by us previously
[5,35,36].
Subsequently, we assessed if REC8 was associated with
centromeres by combining immunostaining with REC8
and a CREST antibody known to detect kinetochore pro-
teins associated with centromeres. This staining revealed
REC8- and CREST-positive foci to be associated and juxta-
posed from day 5 to day 9–11, although somewhat irreg-
ularly. REC8 foci were seen inserted between doublets or
chains of CREST-positive foci (Fig. 4B).
Expression of other meiosis-specific genes
Next, we assessed whether other meiosis specific proteins
were expressed in the lymphoma cells. The DMC1 gene
encodes for a meiosis specific recombinase from the RecA
family and appears to act in cooperation with REC8 [23]
and Rad51 [37]. We found by RT-PCR that DMC1 was
also expressed, both in irradiated and non-treated sam-
ples of all three cell lines, with a prominent decrease after
irradiation in the p53 wild-type TK6 cells (Fig. 3A). We
also found that STAG3, a meiosis-specific cohesin, is tran-
scribed in all three cell lines, although with no apparent
change in transcription after irradiation. The translational
expression of Rad51 in endopolyploid cells, a recombi-
nase engaged in DNA repair, has previously been shown
by us to occur following irradiation in these same p53
mutated cell lines [33]. Studies of the genes involved in
the formation of the synaptonemal complex, SYCP1 and
SYCP3  revealed some weak background expression in
Namalwa cells. Although only weakly transcribed, the
identity of these PCR products was confirmed by sequenc-
ing. The transcriptional expression of these genes was not
elevated by irradiation (Fig. 3C).
On day 6 post-irradiation, approximately 8% of irradiated
Namalwa cell nuclei displayed atypical weak SCP3 stain-
ing by IF in the perinuclear region (not shown).
Discussion
In this study we have investigated the expression of several
meiotic genes in p53 wild-type and p53 mutated lym-
phoma cells both before and after an irradiation insult
that induces mitotic catastrophe. This study reveals that a
In situ localisation of REC8 post-mitotic catastrophe in endopolyploid Namalwa cells: (A) REC8 (red) appears on day 3 in the  metaphase-arrested cells which, as judged by the adhered swollen chromosomes, undergo restitution into endopolyploid cells Figure 4
In situ localisation of REC8 post-mitotic catastrophe in endopolyploid Namalwa cells: (A) REC8 (red) appears on day 3 in the 
metaphase-arrested cells which, as judged by the adhered swollen chromosomes, undergo restitution into endopolyploid cells. 
DNA counterstained by DAPI (blue) (insert- rat testis control for Rec8); (B) IF double-staining for kinetochores/centromeres 
by CREST antibody (FITC, green) and REC8 (red) in a polyploid interphasic cell, where interaction of REC8 foci with kineto-
chores/centromeres is shown; arrow and arrowhead indicate the insertion of several REC8 foci in CREST-positive arrayed 
structures; the image insert shows a higher magnification of a centromere doublet cohesed with a focus of REC8.BMC Cancer 2006, 6:6 http://www.biomedcentral.com/1471-2407/6/6
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group of previously well defined meiosis-specific proteins
are clearly upregulated in the p53 mutated cells after DNA
damage with irradiation. In particular, the meiosis-regula-
tory protein, MOS, was strongly post-transcriptionally up-
regulated in the Namalwa and WIL2NS cells after irradia-
tion. This up-regulation was only apparent in p53
mutated cells and was lacking from the wild-type TK6
cells, implying that up-regulation of MOS by DNA dam-
age is inhibited by wild type p53 function. Interestingly,
this elevation in MOS protein was a post-translational
event as transcription remained constant after irradiation.
Therefore increases in MOS may arise from either
increased translation from the mRNA or increased protein
stability. For example, post-translational modification of
the MOS protein by (auto)phosphorylation on Ser-3
could lead to its increased stability and decreased protea-
some-mediated degradation [14].
This observation of mos upregulation in p53 mutated
cells, is in line with data of Fukasawa and Vande Woude
[38] who demonstrated that only p53-/- somatic cells can
tolerate high levels of MOS and the subsequent down-
stream elevation of MAPK activity. It should also be noted
that up-regulation of MOS protein has been previously
shown in human ovarian cancer cells arrested at the spin-
dle checkpoint by microtubule-damaging agents [39].
Hence, the quantitative and temporal relationship
between MOS up-regulation and the arrest in the spindle
checkpoint were also found in that system, although a dif-
ferent type of tumour cell was used and a different met-
aphase arrest strategy employed. These data strengthen
the notion that MOS expression may be directly involved
in the metaphase arrest in mitotic catastrophe.
During the homologous recombination processes of mei-
osis, Rad51 is known to cooperate with the meiotic
cohesin Rec8 and meiotic recombinase DMC1 [37]. It is
striking that in the irradiated p53 mutant lymphoid
tumours shown here, we observed the expression of a
major meiotic cohesin REC8 and the meiotic recombinase
DMC1. In addition to its potential role in DNA recombi-
nation and repair, the chromatid-cohesing function of
REC8 may also provide for the induction of polyploidis-
ing ('catastrophic') mitosis. Whether it represents an
adaptive response which favours escape from mitotic cell
death, providing an option for the formation of giant
cells, additional DNA repair and their segregation by
somatic reduction still remains to be elucidated.
An interesting and unexpected finding was that a number
of other meiotic prophase-specific genes are also
expressed in the lymphoma cell lines. Importantly, the
induced activation of these meiotic genes seen in the p53
mutated cell lines was not observed in the wild-type p53
TK6 cells. In accord, TK6 cells produce a very small poly-
ploid cell fraction after irradiation, approximately 6 to 10
times less than WI-L2-NS or Namalwa cells and do not
survive the 10 Gy irradiation dose (see Fig. 1).
It is noteworthy that the meiosis-specific genes that were
observed by us to be aberrantly expressed in the p53
mutated lymphoma cells (MOS, REC8, DMC1, STAG3,
SYCP1, and SYCP3) can all be classified as cancer/testis
antigens as defined by Simpson et al. [12]. Many of the
cancer/testis gene products belong to a broad and ever
expanding group of tumour antigens [7,10] and some
have been used, with various success rates, as targets for
vaccine therapy in clinical trials [40].
To our knowledge, four of these meiotic prophase-associ-
ated genes (REC8, DMC1, STAG3 and  SYCP3) are
reported to be expressed in malignant tissue for the first
time. Interestingly, at least a proportion of these meiosis
specific genes appear to be associated with the induction
of mitotic catastrophe and the generation of endopoly-
ploid tumour cells.
Finally, recent advances in long-term video-microscopy
have found that the endopolyploid cells resulting from
mitotic catastrophe appear to have some reproductive
potential [4,41-45]. Given these observations and the
potential importance of the meiosis-specific genes in the
response of p53 mutated tumour cells to genotoxic treat-
ment, further study of these meiotic genes in tumours may
reveal novel therapeutic strategies.
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